J-Pharma Co (TSE:520A) Total Liabilities: 円607.82 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:520A J-Pharma Co Ltd TSE:520A
9 GF Score
Price 円290.00
View Full Analysis

What is J-Pharma Co Total Liabilities?

J-Pharma Co TSE:520A -2.36% 9 Total Liabilities is 円607.82 Mil as of Dec. 2025. GuruFocus rates TSE:520A with a GF Score™ of 9/100.

J-Pharma Co's Total Liabilities for the quarter that ended in Dec. 2025 was 円607.82 Mil.

J-Pharma Co's quarterly Total Liabilities increased from Mar. 2024 (円257.27 Mil) to Mar. 2025 (円478.85 Mil) and increased from Mar. 2025 (円478.85 Mil) to Dec. 2025 (円607.82 Mil).

J-Pharma Co's annual Total Liabilities increased from . 20 (円0.00 Mil) to Mar. 2024 (円257.27 Mil) and increased from Mar. 2024 (円257.27 Mil) to Mar. 2025 (円478.85 Mil).

J-Pharma Co Total Liabilities Historical Data

* Premium members only.

The historical data trend for J-Pharma Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

J-Pharma Co Total Liabilities Chart

J-Pharma Co Annual Data
Trend Mar24 Mar25
Total Liabilities
257.27 478.85

J-Pharma Co Quarterly Data
Mar24 Mar25 Dec25
Total Liabilities 257.27 478.85 607.82
TSE:520A
9GF Score
J-Pharma Co Ltd TSE:520A
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

J-Pharma Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

J-Pharma Co's Total Liabilities for the fiscal year that ended in Mar. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=451.934+(0+0.00099999999999767
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+26.915)
=478.85

Total Liabilities=Total Assets (A: Mar. 2025 )-Total Equity (A: Mar. 2025 )
=2856.719-2377.869
=478.85

J-Pharma Co's Total Liabilities for the quarter that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=602.871+(0+4.9490000000001
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+26.915)
=607.82

Total Liabilities=Total Assets (Q: Dec. 2025 )-Total Equity (Q: Dec. 2025 )
=2952.455-2344.635
=607.82

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of 円607.82 Mil mean?
J-Pharma Co (TSE:520A) has a Total Liabilities of 円607.82 Mil as of Dec. 2025. The total amount of liabilities as recorded on a company's balance sheet. View historical data for J-Pharma Co and its competitors.
Is J-Pharma Co's Total Liabilities too high?
J-Pharma Co's current Total Liabilities is 円607.82 Mil. Overall, J-Pharma Co has a GF Score™ of 9/100, reflecting its overall financial health beyond just this single metric.
How does J-Pharma Co's Total Liabilities compare to VRTX and REGN?
J-Pharma Co's Total Liabilities of 円607.82 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Biotechnology company?
A good Total Liabilities depends on the Biotechnology industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for J-Pharma Co and its competitors. J-Pharma Co's current Total Liabilities is 円607.82 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is J-Pharma Co stock overvalued right now?
J-Pharma Co (TSE:520A) has a current Total Liabilities of 円607.82 Mil. The current Total Liabilities is 円607.82 Mil. J-Pharma Co's overall GF Score™ is 9/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For J-Pharma Co (TSE:520A), the current Total Liabilities is 円607.82 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

J-Pharma Co Business Description

Address 1-10-11, HamamatsuCho, 8th floor, Minato-Ku, Tokyo, JPN, 105-0013
J-Pharma Co Ltd is engaged in the Drug discovery and development targeting SLC transporters. It is focused on a single segment of the drug discovery business, focusing on R&D and clinical development. The company's two compounds in clinical development are Nanbran Latte (JPH203) and JPH034.
9GF Score

Get the complete analysis for TSE:520A

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円290.00
Price